Загрузка...
Gene Therapy for Hemophilia: Facts and Quandaries in the 21st Century
Therapy for hemophilia has evolved in the last 40 years from plasma-based concentrates to recombinant proteins and, more recently, to non-factor therapeutics. Along this same timeline, research in adeno-associated viral (AAV) based gene therapy vectors has provided the framework for early phase clin...
Сохранить в:
| Опубликовано в: : | Mediterr J Hematol Infect Dis |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Università Cattolica del Sacro Cuore
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7485465/ https://ncbi.nlm.nih.gov/pubmed/32952980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2020.069 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|